CASC8
REGENERATIVE MEDICINE
Regenerating The Human Heart
CASC8 is a Belgian biotechnology company pioneering a breakthrough regenerative therapy for patients with heart failure and ischemic heart disease.
​
Founded in 2016 by Prof. Dr. Marc Hendrikx, a cardiac surgeon and professor of regenerative medicine at UHasselt (Belgium), CASC8 builds on more than a decade of research into cardiac-derived stem cells and the heart’s natural ability to heal itself.
​
Our mission is clear and bold: to develop a safe, clinically validated therapy that enables the human heart to regenerate, transforming the future of cardiology.
Mission
To develop a safe, clinically realistic therapy that allows the heart to heal itself.
Vision
A future where heart failure is no longer managed, but truly regenerated.
CASC8 — Where Science Heals The Heart
Connect With Us
We welcome inquiries from scientists, potential partners, and investors
who share our vision of a regenerative future in cardiology.
Whether you are interested in collaboration, scientific discussion,
or exploring investment opportunities,
please reach out.
We look forward to connecting with you.